| scholarly article | Q13442814 |
| P2093 | author name string | Min Guo | |
| Gang Shi | |||
| Yong Zhao | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis | Q30240765 | ||
| Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study | Q33975575 | ||
| Gene therapy for restenosis--what now, what next? | Q35794256 | ||
| Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis | Q35927338 | ||
| Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation | Q36052078 | ||
| Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention | Q36836647 | ||
| Prediabetes: a high-risk state for diabetes development. | Q37476370 | ||
| Cardiovascular disease in diabetes mellitus: risk factors and medical therapy | Q38192230 | ||
| Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study | Q51370555 | ||
| Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation | Q51888144 | ||
| The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent | Q52943468 | ||
| Current Management of In-Stent Restenosis. | Q55005923 | ||
| The Impact of Prediabetes on Two-Year Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention. | Q55023261 | ||
| Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance | Q58053345 | ||
| Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus | Q61807469 | ||
| Global epidemiology of prediabetes - present and future perspectives | Q64059807 | ||
| In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention: A meta-analysis including 139,774 patients | Q64113067 | ||
| Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes Mellitus | Q84718638 | ||
| Prediabetes and macrovascular disease: Review of the association, influence on outcome and effect of treatment | Q90213685 | ||
| 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019 | Q90595498 | ||
| Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline | Q92308945 | ||
| Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial | Q38451162 | ||
| Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-elutin | Q38487695 | ||
| Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury | Q38603120 | ||
| Prevalence and prevention of cardiovascular disease and diabetes mellitus | Q38971154 | ||
| Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes | Q39107844 | ||
| Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention | Q40510941 | ||
| High rate of abnormal glucose tolerance in Brazilian individuals undergoing coronary angiography | Q41431719 | ||
| Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study | Q43864405 | ||
| Association of prediabetes with diffuse coronary narrowing and small-vessel disease. | Q43977610 | ||
| Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention. | Q45933717 | ||
| Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. | Q46056371 | ||
| Comparison of myocardial reperfusion in patients with fasting blood glucose < or =100, 101 to 125, and >125 mg/dl and ST-elevation myocardial infarction with percutaneous coronary intervention | Q46233492 | ||
| Prognostic value of impaired fasting glucose for outcomes of patients with stable angina pectoris treated with percutaneous coronary interventions | Q46743742 | ||
| Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus | Q46794309 | ||
| Abnormal glucose regulation in Chinese patients with coronary artery disease: A cross-sectional study. | Q49556906 | ||
| "Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study. | Q49897218 | ||
| Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study | Q50064019 | ||
| Prediabetes and its Impact on Clinical Outcome After Coronary Intervention in a Broad Patient Population | Q50125818 | ||
| Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction | Q50179665 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P577 | publication date | 2020-01-01 | |
| P1433 | published in | Bioscience Reports | Q2790714 |
| P1476 | title | Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis | |
| P478 | volume | 40 |
Search more.